Ultrasensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) detection in early stage non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Isbell, James M.
Goldstein, Jordan Scott
Hamilton, Emily G.
Liu, Si-Yang
Eichholz, Jordan
Buonocore, Darren J.
Rusch, Valerie W.
Bott, Matthew
Molena, Daniela
Rocco, Gaetano
Yang, Soo-Ryum
Rudin, Charles M.
Jones, David R.
Roff, Alanna
Schultz, Andre
Chabon, Jake J.
Kurtz, David Matthew
Alizadeh, Ash A.
Li, Bob T.
Diehn, Maximilian
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Stanford Canc Ctr, Palo Alto, CA USA
[3] Stanford Univ, Stanford, CA USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, Div Thorac Surg, New York, NY USA
[6] Foresight Diagnost, Aurora, CO USA
[7] Stanford Univ, Med Ctr, Stanford, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8078
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Circulating tumor DNA (ctDNA) as a marker of minimal residual disease (MRD) in localized non-small cell lung carcinoma (NSCLC).
    Simon, Nicholas I.
    Davis, Andrew A.
    Mohindra, Nisha Anjali
    Villaflor, Victoria Meucci
    Chae, Young Kwang
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Personalized tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in resected non-small cell lung cancer (NSCLC) with common driver genes
    Zhong, R.
    Liang, H.
    Jiang, Y.
    Lin, Y.
    Fu, W.
    Xiong, Y.
    Xiong, S.
    Wang, R.
    Ye, Z.
    Li, X.
    Li, J.
    Li, F.
    Wang, H.
    Xiang, Y.
    Yu, Z.
    Zhan, S.
    Chen, P.
    Zheng, X.
    Liang, W.
    He, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S735 - S735
  • [3] Mathematical modeling of ctDNA dynamics to predict utility of ultrasensitive MRD assays in early stage non-small cell lung cancer (NSCLC)
    Goldstein, Jordan S.
    Abbosh, Christopher
    Alizadeh, Ash A.
    Diehn, Maximilian
    Kurtz, David M.
    CANCER RESEARCH, 2024, 84 (06)
  • [4] The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer
    Verlicchi, Alberto
    Canale, Matteo
    Chiadini, Elisa
    Cravero, Paola
    Urbini, Milena
    Andrikou, Kalliopi
    Pasini, Luigi
    Flospergher, Michele
    Burgio, Marco Angelo
    Crino, Lucio
    Ulivi, Paola
    Delmonte, Angelo
    LIFE-BASEL, 2023, 13 (09):
  • [5] Circulating tumor DNA minimal residual disease in clinical practice of non-small cell lung cancer
    Xia, Jinghua
    Zhang, Jiao
    Xiong, Yanlu
    Zhao, Jinbo
    Zhou, Yinxi
    Jiang, Tao
    Zhu, Jianfei
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2023, 23 (10) : 913 - 924
  • [6] Potential utility of methylation levels detected from circulating tumor DNA (ctDNA) in predicting molecular residual disease (MRD) in patients with resected non-small cell lung cancer (NSCLC).
    Hu, Hong
    Li, Hang
    Ma, Zelin
    Xiang, Jiaqing
    Zhang, Yawei
    Lizaso, Analyn
    Hou, Ting
    Guan, Xiaoqian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] ctDNA detection in early stage non-small cell lung cancer
    Heider, Katrin
    Wan, Jonathan C.
    Gale, Davina
    Ruiz-Valdepenas, Andrea
    Mouliere, Florent
    Morris, James
    Qureshi, Nagmi R.
    Qian, Wendi
    Wulff, Jerome
    Demiris, Nikolaos
    Howarth, Karen
    Green, Emma
    Rundell, Viona
    Eisen, Tim
    Cooper, Wendy
    Smith, Christopher G.
    Massie, Charles
    Harden, Susan
    Rassl, Doris M.
    Rintoul, Robert C.
    Rosenfeld, Nitzan
    CANCER RESEARCH, 2020, 80 (16)
  • [8] Ultrasensitive Detection of Circulating Tumor DNA in Non-Small Cell Lung Cancer by Deep Sequencing
    Diehn, M.
    Bratman, S. V.
    Newman, A. M.
    Neal, J. W.
    Wakelee, H. A.
    Merritt, R. E.
    Shrager, J. B.
    Loo, B. W.
    Alizadeh, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S75 - S75
  • [9] Prognostic Role of Circulating Tumor DNA (ctDNA) and Immune Cell Biomarkers in Non-Small Cell Lung Cancer (NSCLC)
    Chae, Y. K.
    Agte, S.
    Davis, A.
    Pan, A.
    Simon, N.
    Mohindra, N.
    Villaflor, V.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2242 - S2242
  • [10] Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer
    Fang, Xiaoxu
    Yu, Shaokun
    Jiang, Yingying
    Xiang, Yan
    Lu, Kaihua
    FRONTIERS IN ONCOLOGY, 2022, 12
12345